Empagliflozin use in patients with type 2 diabetes (T2D) has not been shown to have a higher risk of urinary tract cancers (UTCs), such as bladder and renal cancers, compared to dipeptidyl peptidase-4 inhibitors (DPP-4i), according to researchers. The research provides reassurance about the cancer safety profile of empagliflozin, a widely prescribed sodium-glucose co-transporter 2 […]
New Delhi: The Union Health Ministry is planning a regulatory overhaul that could result in the immediate suspension of product licenses for drugmakers whose products are declared not of standard quality (NSQ) by government testing laboratories. The move, aimed at ensuring drug quality and public safety, is currently under discussion with various state regulators. According […]
Using machine learning models researchers have found in a new study that increased physical activity and reduced sedentary time significantly lower the risk of developing gout in individuals with hyperuricemia. Individuals with hyperuricemia (HUA) are widely recognized as being at increased risk for gout. This study aimed to investigate how physical activity (PA) duration and […]
New Delhi: Bharat Serums and Vaccines has received approval from the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation (CDSCO) to conduct a Phase III clinical trial of Human Normal Immunoglobulin for Intravenous Use (IVIG) 5% Solution. This came after the firm presented the revised protocol — updated as per the […]
New Delhi: In a step toward advancing medical device-based cancer care, the Subject Expert Committee (SEC) under the Oncology division of the Central Drugs Standard Control Organisation (CDSCO) has granted permission to conduct a pilot clinical investigation of the Hemopurifier device in India. The proposal, submitted by Qualtran Consulting, was reviewed during the 19th SEC […]
New Delhi: The apex research regulator, the Indian Council of Medical Research (ICMR), is set to strengthen outbreak response and bolster public health delivery by procuring two more Mobile BSL-3 (MBSL-3) laboratories, targeting especially remote and inaccessible areas. Called RAMBAAN, there are currently two such laboratories – each stationed at ICMR’s two institutes, the National Institute of Virology […]
Cambridge: AstraZeneca and Daiichi Sankyo have announced that Datroway (datopotamab deruxtecan or Dato-DXd) has received accelerated approval from the Food and Drug Administration (FDA) for the treatment of adult patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC) who have received prior EGFR-directed therapy and platinum-based chemotherapy. This indication is approved under accelerated approval based on objective response rate […]
Thin-Fat Paradox in Indian T2DM – A Distinct Metabolic Challenge: In the Indian population, the ‘thin-fat’ phenotype-normal BMI with excess visceral and reduced peripheral fat-represents a distinct metabolic risk. Nearly one-third of Indian adults with a BMI <25 kg/m² may exhibit this profile, with a 2.7-fold higher risk of type 2 diabetes.(1) As BMI inadequately […]
Ludhiana: In a bid to improve healthcare services and curb ongoing irregularities, Punjab Health and Family Welfare Minister Dr Balbir Singh made a surprise visit to the Civil Hospital in Ludhiana on Monday. The minister inspected the hospital’s facilities and assessed the quality of patient care being delivered. During his visit, Dr. Singh expressed concern over thefts […]
Lucknow: Uttar Pradesh Deputy Chief Minister and Health Minister Brajesh Pathak on Monday announced significant changes in the designation and recruitment criteria for nursing staff within the state’s health department. The changes align with the central government’s health department norms and aim to upgrade the status and recognition of nurses. Speaking to Hindustan Times, Pathak said, […]